proteinuria
Advertisement
Phase 3 VISIONARY trial data showed sibeprenlimab helps achieve significant proteinuria reduction in IgAN.
Pegcetacoplan reduced proteinuria and stabilized eGFR in adolescent patients with C3G or primary IC-MPGN.
An analysis confirmed the efficacy and safety of pegcetacoplan for patients with C3G/IC-MPGN and nephrotic range proteinuria.
Long-term data demonstrated that zigakibart reduced proteinuria and stabilized kidney function of patients with IgAN.
Nefecon can safely be used to treat severe renal impairment and lowers proteinuria in patients with IgAN.
Proteinuria trajectory is a major predictor of disease progression in children and adults with IgAN, a study found.
Joel Topf caught up with James Tumlin at NKF SCM25 to talk about Dr. Tumlin's late-breaking abstract on sparsentan in FSGS.
One-year results of the AFFINITY trial of atrasentan to treat proteinuria among patients with IgAN were presented at SCM25.
Research compared the effects of sparsentan and irbesartan on proteinuria remission in focal segmental glomerulosclerosis.
Do changes in UPCR during severe AKI episodes affect how serum creatinine levels change at the time of sample collection?
Interim APPLAUSE-IgAN data showed that iptacopan was superior to placebo at reducing proteinuria at nine months.
Zigakibart for treatment of IgA nephropathy (IgAN) was well tolerated, reduced proteinuria, and stabilized eGFR at 76 weeks.
Even when levels are below the current KDIGO threshold, proteinuria in IgAN indicates a risk of kidney failure.
SGLT2i are associated with a significant reduction of proteinuria, especially for patients with higher BMI.
According to a study, published in ESMO Open, no biomarkers have been validated for predicting efficacy outcomes in ...
Patients with hospitalized with COVID-19 frequently develop acute kidney injury (AKI) and may require renal replacement ...
Proteinuria is known as independent risk factor for cardiovascular disease in kidney transplant recipients. However, ...
Achieving complete or partial remission of proteinuria is associated with better long-term outcomes in patients with ...
A study sought to discern whether reductions in proteinuria following treatment for focal segmental glomerulosclerosis ...
A study sought to discern surrogate endpoints that could serve as robust predictors of treatment efficacy on long-term ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.